APO Research
Talk to an analyst

APO RESEARCH · REPORT

Ovarian Reserve Testing

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ovarian Reserve Testing Market Analysis and Forecast 2026-2032

31 December 2025198 pages

Choose your research edition.

Industry ResearchOvarian Reserve Testing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Ovarian Reserve Testing Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Ovarian Reserve Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ovarian Reserve Testing Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Ovarian Reserve Testing Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Ovarian Reserve Testing market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Ovarian Reserve Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ovarian Reserve Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ovarian Reserve Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ovarian Reserve Testing is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Ovarian Reserve Testing include VIDAS, Modern Fertility, LetsGetChecked, LabCorp, Future Family, Fujirebio, F. Hoffmann-La Roche Ltd, Everlywell and EggQ, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Ovarian Reserve Testing, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ovarian Reserve Testing, also provides the revenue of main regions and countries. Of the upcoming market potential for Ovarian Reserve Testing, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ovarian Reserve Testing revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ovarian Reserve Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Ovarian Reserve Testing revenue, projected growth trends, production technology, application and end-user industry.

Ovarian Reserve Testing Segment by Company

VIDAS

Modern Fertility

LetsGetChecked

LabCorp

Future Family

Fujirebio

F. Hoffmann-La Roche Ltd

Everlywell

EggQ

Beckman Coulter

Ovarian Reserve Testing Segment by Type

Follicle Stimulating Hormone (FSH) Testing

Antral Follicle Count Testing

Basal Follicle Stimulating Hormone Testing

Anti-Mullerian hormone (AMH) Testing

Ovarian Reserve Testing Segment by Application

Hospital

Clinic

Ovarian Reserve Testing Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ovarian Reserve Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ovarian Reserve Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ovarian Reserve Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Ovarian Reserve Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Ovarian Reserve Testing company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ovarian Reserve Testing revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ovarian Reserve Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Follicle Stimulating Hormone (FSH) Testing Major Player Table 3. Antral Follicle Count Testing Major Player Table 4. Basal Follicle Stimulating Hormone Testing Major Player Table 5. Anti-Mullerian hormone (AMH) Testing Major Player Table 6. Global Ovarian Reserve Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Hospital Major Player Table 8. Clinic Major Player Table 9. Ovarian Reserve Testing Industry Trends Table 10. Ovarian Reserve Testing Industry Drivers Table 11. Ovarian Reserve Testing Industry Opportunities and Challenges Table 12. Ovarian Reserve Testing Industry Restraints Table 13. Global Ovarian Reserve Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Ovarian Reserve Testing Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Ovarian Reserve Testing Market Share by Region (2021-2026) Table 16. Global Ovarian Reserve Testing Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Ovarian Reserve Testing Market Share by Region (2027-2032) Table 18. Global Ovarian Reserve Testing Revenue by Players (US$ Million) & (2021-2026) Table 19. Global Ovarian Reserve Testing Revenue Market Share by Players (2021-2026) Table 20. Global Ovarian Reserve Testing Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global Ovarian Reserve Testing Key Players Headquarters & Area Served Table 22. Global Ovarian Reserve Testing Players, Product Type & Application Table 23. Global Ovarian Reserve Testing Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global Ovarian Reserve Testing by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global Ovarian Reserve Testing Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Ovarian Reserve Testing Revenue by Type (2021-2026) & (US$ Million) Table 28. Global Ovarian Reserve Testing Revenue by Type (2027-2032) & (US$ Million) Table 29. Global Ovarian Reserve Testing Revenue Market Share by Type (2021-2026) Table 30. Global Ovarian Reserve Testing Revenue Market Share by Type (2027-2032) Table 31. Global Ovarian Reserve Testing Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Ovarian Reserve Testing Revenue by Application (2021-2026) & (US$ Million) Table 33. Global Ovarian Reserve Testing Revenue by Application (2027-2032) & (US$ Million) Table 34. Global Ovarian Reserve Testing Revenue Market Share by Application (2021-2026) Table 35. Global Ovarian Reserve Testing Revenue Market Share by Application (2027-2032) Table 36. VIDAS Company Information Table 37. VIDAS Business Overview Table 38. VIDAS Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. VIDAS Ovarian Reserve Testing Product Portfolio Table 40. VIDAS Recent Development Table 41. Modern Fertility Company Information Table 42. Modern Fertility Business Overview Table 43. Modern Fertility Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Modern Fertility Ovarian Reserve Testing Product Portfolio Table 45. Modern Fertility Recent Development Table 46. LetsGetChecked Company Information Table 47. LetsGetChecked Business Overview Table 48. LetsGetChecked Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. LetsGetChecked Ovarian Reserve Testing Product Portfolio Table 50. LetsGetChecked Recent Development Table 51. LabCorp Company Information Table 52. LabCorp Business Overview Table 53. LabCorp Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. LabCorp Ovarian Reserve Testing Product Portfolio Table 55. LabCorp Recent Development Table 56. Future Family Company Information Table 57. Future Family Business Overview Table 58. Future Family Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Future Family Ovarian Reserve Testing Product Portfolio Table 60. Future Family Recent Development Table 61. Fujirebio Company Information Table 62. Fujirebio Business Overview Table 63. Fujirebio Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Fujirebio Ovarian Reserve Testing Product Portfolio Table 65. Fujirebio Recent Development Table 66. F. Hoffmann-La Roche Ltd Company Information Table 67. F. Hoffmann-La Roche Ltd Business Overview Table 68. F. Hoffmann-La Roche Ltd Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. F. Hoffmann-La Roche Ltd Ovarian Reserve Testing Product Portfolio Table 70. F. Hoffmann-La Roche Ltd Recent Development Table 71. Everlywell Company Information Table 72. Everlywell Business Overview Table 73. Everlywell Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Everlywell Ovarian Reserve Testing Product Portfolio Table 75. Everlywell Recent Development Table 76. EggQ Company Information Table 77. EggQ Business Overview Table 78. EggQ Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. EggQ Ovarian Reserve Testing Product Portfolio Table 80. EggQ Recent Development Table 81. Beckman Coulter Company Information Table 82. Beckman Coulter Business Overview Table 83. Beckman Coulter Ovarian Reserve Testing Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Beckman Coulter Ovarian Reserve Testing Product Portfolio Table 85. Beckman Coulter Recent Development Table 86. North America Ovarian Reserve Testing Revenue by Type (2021-2026) & (US$ Million) Table 87. North America Ovarian Reserve Testing Revenue by Type (2027-2032) & (US$ Million) Table 88. North America Ovarian Reserve Testing Revenue by Application (2021-2026) & (US$ Million) Table 89. North America Ovarian Reserve Testing Revenue by Application (2027-2032) & (US$ Million) Table 90. North America Ovarian Reserve Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America Ovarian Reserve Testing Revenue by Country (2021-2026) & (US$ Million) Table 92. North America Ovarian Reserve Testing Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe Ovarian Reserve Testing Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe Ovarian Reserve Testing Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe Ovarian Reserve Testing Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe Ovarian Reserve Testing Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe Ovarian Reserve Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Ovarian Reserve Testing Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe Ovarian Reserve Testing Revenue by Country (US$ Million) & (2027-2032) Table 100. China Ovarian Reserve Testing Revenue by Type (2021-2026) & (US$ Million) Table 101. China Ovarian Reserve Testing Revenue by Type (2027-2032) & (US$ Million) Table 102. China Ovarian Reserve Testing Revenue by Application (2021-2026) & (US$ Million) Table 103. China Ovarian Reserve Testing Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia Ovarian Reserve Testing Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia Ovarian Reserve Testing Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia Ovarian Reserve Testing Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia Ovarian Reserve Testing Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia Ovarian Reserve Testing Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia Ovarian Reserve Testing Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia Ovarian Reserve Testing Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA Ovarian Reserve Testing Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA Ovarian Reserve Testing Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA Ovarian Reserve Testing Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA Ovarian Reserve Testing Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA Ovarian Reserve Testing Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA Ovarian Reserve Testing Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA Ovarian Reserve Testing Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Ovarian Reserve Testing Image Figure 2. Global Ovarian Reserve Testing Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ovarian Reserve Testing Market Size Share 2021 VS 2025 VS 2032 Figure 4. Follicle Stimulating Hormone (FSH) Testing Image Figure 5. Antral Follicle Count Testing Image Figure 6. Basal Follicle Stimulating Hormone Testing Image Figure 7. Anti-Mullerian hormone (AMH) Testing Image Figure 8. Global Ovarian Reserve Testing Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Ovarian Reserve Testing Market Size Share 2021 VS 2025 VS 2032 Figure 10. Hospital Image Figure 11. Clinic Image Figure 12. Global Ovarian Reserve Testing Market Size (US$ Million) & (2021-2032) Figure 13. Global Ovarian Reserve Testing Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Ovarian Reserve Testing Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global Ovarian Reserve Testing Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Ovarian Reserve Testing Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Ovarian Reserve Testing Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Ovarian Reserve Testing Revenue Market Share by Type (2021-2032) Figure 20. Global Ovarian Reserve Testing Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Ovarian Reserve Testing Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global Ovarian Reserve Testing Revenue Market Share by Application (2021-2032) Figure 23. North America Ovarian Reserve Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Ovarian Reserve Testing Revenue Share by Type (2021-2032) Figure 25. North America Ovarian Reserve Testing Revenue Share by Application (2021-2032) Figure 26. North America Ovarian Reserve Testing Revenue Share by Country (2021-2032) Figure 27. United States Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe Ovarian Reserve Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe Ovarian Reserve Testing Revenue Share by Type (2021-2032) Figure 32. Europe Ovarian Reserve Testing Revenue Share by Application (2021-2032) Figure 33. Europe Ovarian Reserve Testing Revenue Share by Country (2021-2032) Figure 34. Germany Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China Ovarian Reserve Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China Ovarian Reserve Testing Revenue Share by Type (2021-2032) Figure 44. China Ovarian Reserve Testing Revenue Share by Application (2021-2032) Figure 45. Asia Ovarian Reserve Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia Ovarian Reserve Testing Revenue Share by Type (2021-2032) Figure 47. Asia Ovarian Reserve Testing Revenue Share by Application (2021-2032) Figure 48. Asia Ovarian Reserve Testing Revenue Share by Region (2021-2032) Figure 49. Japan Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA Ovarian Reserve Testing Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA Ovarian Reserve Testing Revenue Share by Type (2021-2032) Figure 57. SAMEA Ovarian Reserve Testing Revenue Share by Application (2021-2032) Figure 58. SAMEA Ovarian Reserve Testing Revenue Share by Country (2021-2032) Figure 59. Brazil Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt Ovarian Reserve Testing Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Follicle Stimulating Hormone (FSH) Testing
  • Antral Follicle Count Testing
  • Basal Follicle Stimulating Hormone Testing
  • Anti-Mullerian hormone (AMH) Testing
Applications
  • Hospital
  • Clinic
Companies covered
  • VIDAS
  • Modern Fertility
  • LetsGetChecked
  • LabCorp
  • Future Family
  • Fujirebio
  • F. Hoffmann-La Roche Ltd
  • Everlywell
  • EggQ
  • Beckman Coulter

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ovarian Reserve Testing Market by Type
  3. 1.2.1 Global Ovarian Reserve Testing Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Follicle Stimulating Hormone (FSH) Testing
  5. 1.2.3 Antral Follicle Count Testing
  6. 1.2.4 Basal Follicle Stimulating Hormone Testing
  7. 1.2.5 Anti-Mullerian hormone (AMH) Testing
  8. 1.3 Ovarian Reserve Testing Market by Application
  9. 1.3.1 Global Ovarian Reserve Testing Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Hospital
  11. 1.3.3 Clinic
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Ovarian Reserve Testing Market Dynamics
  1. 2.1 Ovarian Reserve Testing Industry Trends
  2. 2.2 Ovarian Reserve Testing Industry Drivers
  3. 2.3 Ovarian Reserve Testing Industry Opportunities and Challenges
  4. 2.4 Ovarian Reserve Testing Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Ovarian Reserve Testing Market Perspective (2021-2032)
  2. 3.2 Global Ovarian Reserve Testing Growth Trends by Region
  3. 3.2.1 Global Ovarian Reserve Testing Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ovarian Reserve Testing Market Size by Region (2021-2026)
  5. 3.2.3 Global Ovarian Reserve Testing Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Ovarian Reserve Testing Revenue by Players
  2. 4.1.1 Global Ovarian Reserve Testing Revenue by Players (2021-2026)
  3. 4.1.2 Global Ovarian Reserve Testing Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Ovarian Reserve Testing Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ovarian Reserve Testing Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Ovarian Reserve Testing Key Players Headquarters & Area Served
  7. 4.4 Global Ovarian Reserve Testing Players, Product Type & Application
  8. 4.5 Global Ovarian Reserve Testing Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Ovarian Reserve Testing Market CR5 and HHI
  11. 4.6.3 2025 Ovarian Reserve Testing Tier 1, Tier 2, and Tier 3
5 Ovarian Reserve Testing Market Size by Type
  1. 5.1 Global Ovarian Reserve Testing Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Ovarian Reserve Testing Revenue by Type (2021-2032)
  3. 5.3 Global Ovarian Reserve Testing Revenue Market Share by Type (2021-2032)
6 Ovarian Reserve Testing Market Size by Application
  1. 6.1 Global Ovarian Reserve Testing Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Ovarian Reserve Testing Revenue by Application (2021-2032)
  3. 6.3 Global Ovarian Reserve Testing Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 VIDAS
  2. 7.1.1 VIDAS Company Information
  3. 7.1.2 VIDAS Business Overview
  4. 7.1.3 VIDAS Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  5. 7.1.4 VIDAS Ovarian Reserve Testing Product Portfolio
  6. 7.1.5 VIDAS Recent Developments
  7. 7.2 Modern Fertility
  8. 7.2.1 Modern Fertility Company Information
  9. 7.2.2 Modern Fertility Business Overview
  10. 7.2.3 Modern Fertility Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Modern Fertility Ovarian Reserve Testing Product Portfolio
  12. 7.2.5 Modern Fertility Recent Developments
  13. 7.3 LetsGetChecked
  14. 7.3.1 LetsGetChecked Company Information
  15. 7.3.2 LetsGetChecked Business Overview
  16. 7.3.3 LetsGetChecked Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  17. 7.3.4 LetsGetChecked Ovarian Reserve Testing Product Portfolio
  18. 7.3.5 LetsGetChecked Recent Developments
  19. 7.4 LabCorp
  20. 7.4.1 LabCorp Company Information
  21. 7.4.2 LabCorp Business Overview
  22. 7.4.3 LabCorp Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  23. 7.4.4 LabCorp Ovarian Reserve Testing Product Portfolio
  24. 7.4.5 LabCorp Recent Developments
  25. 7.5 Future Family
  26. 7.5.1 Future Family Company Information
  27. 7.5.2 Future Family Business Overview
  28. 7.5.3 Future Family Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Future Family Ovarian Reserve Testing Product Portfolio
  30. 7.5.5 Future Family Recent Developments
  31. 7.6 Fujirebio
  32. 7.6.1 Fujirebio Company Information
  33. 7.6.2 Fujirebio Business Overview
  34. 7.6.3 Fujirebio Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Fujirebio Ovarian Reserve Testing Product Portfolio
  36. 7.6.5 Fujirebio Recent Developments
  37. 7.7 F. Hoffmann-La Roche Ltd
  38. 7.7.1 F. Hoffmann-La Roche Ltd Company Information
  39. 7.7.2 F. Hoffmann-La Roche Ltd Business Overview
  40. 7.7.3 F. Hoffmann-La Roche Ltd Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  41. 7.7.4 F. Hoffmann-La Roche Ltd Ovarian Reserve Testing Product Portfolio
  42. 7.7.5 F. Hoffmann-La Roche Ltd Recent Developments
  43. 7.8 Everlywell
  44. 7.8.1 Everlywell Company Information
  45. 7.8.2 Everlywell Business Overview
  46. 7.8.3 Everlywell Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Everlywell Ovarian Reserve Testing Product Portfolio
  48. 7.8.5 Everlywell Recent Developments
  49. 7.9 EggQ
  50. 7.9.1 EggQ Company Information
  51. 7.9.2 EggQ Business Overview
  52. 7.9.3 EggQ Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  53. 7.9.4 EggQ Ovarian Reserve Testing Product Portfolio
  54. 7.9.5 EggQ Recent Developments
  55. 7.10 Beckman Coulter
  56. 7.10.1 Beckman Coulter Company Information
  57. 7.10.2 Beckman Coulter Business Overview
  58. 7.10.3 Beckman Coulter Ovarian Reserve Testing Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Beckman Coulter Ovarian Reserve Testing Product Portfolio
  60. 7.10.5 Beckman Coulter Recent Developments
8 North America
  1. 8.1 North America Ovarian Reserve Testing Revenue (2021-2032)
  2. 8.2 North America Ovarian Reserve Testing Revenue by Type (2021-2032)
  3. 8.2.1 North America Ovarian Reserve Testing Revenue by Type (2021-2026)
  4. 8.2.2 North America Ovarian Reserve Testing Revenue by Type (2027-2032)
  5. 8.3 North America Ovarian Reserve Testing Revenue Share by Type (2021-2032)
  6. 8.4 North America Ovarian Reserve Testing Revenue by Application (2021-2032)
  7. 8.4.1 North America Ovarian Reserve Testing Revenue by Application (2021-2026)
  8. 8.4.2 North America Ovarian Reserve Testing Revenue by Application (2027-2032)
  9. 8.5 North America Ovarian Reserve Testing Revenue Share by Application (2021-2032)
  10. 8.6 North America Ovarian Reserve Testing Revenue by Country
  11. 8.6.1 North America Ovarian Reserve Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Ovarian Reserve Testing Revenue by Country (2021-2026)
  13. 8.6.3 North America Ovarian Reserve Testing Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
9 Europe
  1. 9.1 Europe Ovarian Reserve Testing Revenue (2021-2032)
  2. 9.2 Europe Ovarian Reserve Testing Revenue by Type (2021-2032)
  3. 9.2.1 Europe Ovarian Reserve Testing Revenue by Type (2021-2026)
  4. 9.2.2 Europe Ovarian Reserve Testing Revenue by Type (2027-2032)
  5. 9.3 Europe Ovarian Reserve Testing Revenue Share by Type (2021-2032)
  6. 9.4 Europe Ovarian Reserve Testing Revenue by Application (2021-2032)
  7. 9.4.1 Europe Ovarian Reserve Testing Revenue by Application (2021-2026)
  8. 9.4.2 Europe Ovarian Reserve Testing Revenue by Application (2027-2032)
  9. 9.5 Europe Ovarian Reserve Testing Revenue Share by Application (2021-2032)
  10. 9.6 Europe Ovarian Reserve Testing Revenue by Country
  11. 9.6.1 Europe Ovarian Reserve Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Ovarian Reserve Testing Revenue by Country (2021-2026)
  13. 9.6.3 Europe Ovarian Reserve Testing Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Netherlands
  19. 9.6.9 Nordic Countries
10 China
  1. 10.1 China Ovarian Reserve Testing Revenue (2021-2032)
  2. 10.2 China Ovarian Reserve Testing Revenue by Type (2021-2032)
  3. 10.2.1 China Ovarian Reserve Testing Revenue by Type (2021-2026)
  4. 10.2.2 China Ovarian Reserve Testing Revenue by Type (2027-2032)
  5. 10.3 China Ovarian Reserve Testing Revenue Share by Type (2021-2032)
  6. 10.4 China Ovarian Reserve Testing Revenue by Application (2021-2032)
  7. 10.4.1 China Ovarian Reserve Testing Revenue by Application (2021-2026)
  8. 10.4.2 China Ovarian Reserve Testing Revenue by Application (2027-2032)
  9. 10.5 China Ovarian Reserve Testing Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ovarian Reserve Testing Revenue (2021-2032)
  2. 11.2 Asia Ovarian Reserve Testing Revenue by Type (2021-2032)
  3. 11.2.1 Asia Ovarian Reserve Testing Revenue by Type (2021-2026)
  4. 11.2.2 Asia Ovarian Reserve Testing Revenue by Type (2027-2032)
  5. 11.3 Asia Ovarian Reserve Testing Revenue Share by Type (2021-2032)
  6. 11.4 Asia Ovarian Reserve Testing Revenue by Application (2021-2032)
  7. 11.4.1 Asia Ovarian Reserve Testing Revenue by Application (2021-2026)
  8. 11.4.2 Asia Ovarian Reserve Testing Revenue by Application (2027-2032)
  9. 11.5 Asia Ovarian Reserve Testing Revenue Share by Application (2021-2032)
  10. 11.6 Asia Ovarian Reserve Testing Revenue by Country
  11. 11.6.1 Asia Ovarian Reserve Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Ovarian Reserve Testing Revenue by Country (2021-2026)
  13. 11.6.3 Asia Ovarian Reserve Testing Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ovarian Reserve Testing Revenue (2021-2032)
  2. 12.2 SAMEA Ovarian Reserve Testing Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Ovarian Reserve Testing Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Ovarian Reserve Testing Revenue by Type (2027-2032)
  5. 12.3 SAMEA Ovarian Reserve Testing Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Ovarian Reserve Testing Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Ovarian Reserve Testing Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Ovarian Reserve Testing Revenue by Application (2027-2032)
  9. 12.5 SAMEA Ovarian Reserve Testing Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Ovarian Reserve Testing Revenue by Country
  11. 12.6.1 SAMEA Ovarian Reserve Testing Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Ovarian Reserve Testing Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Ovarian Reserve Testing Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst